Last updated on March 2019

Lynparza Breast Cancer Clinical Experience Investigation


Brief description of study

To characterise the development of ADRs of bone marrow depression in patients under actual post-marketing use.

Detailed Study Description

To characterise the development of adverse drug reactions (ADRs) of bone marrow depression in patients with unresectable or recurrent BRCA mutated HER2 negative breast cancer who have previously received anticancer chemotherapy under actual post-marketing use.

Clinical Study Identifier: NCT03590938

Contact Investigators or Research Sites near you

Start Over

AstraZeneca Clinical Study Information Center

Research Site
Kanagawa, Japan
0.36miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.